Therefore, the cost of recombinant MCP
production was less than other methods such as IPTG inducement. It
is crucial for vaccine development to determine the optimal immune
dosage. In the present study mandarin fish could obtained better
protection against ISKNV challenge post-vaccinated with recombinant
MCP at a dose 50 mg/fish.